- Statement from CMTA’s Chief Executive Officer, Sue Bruhn, PhD
Dear Members of the CMT Community, The Charcot-Marie-Tooth Association (CMTA) continues to prioritize the well-being of the CMT community. Advocating for improved access to care as well as the acceleration of research, CMTA is working closely with our partners to ensure ...Read more ... - CMTA-STAR Clinical Expert Board Co-Chair Prof. Mary Reilly Honored with Prestigious MBEThe Charcot-Marie-Tooth Association proudly celebrates Professor Mary M. Reilly, MD, CMTA-STAR Clinical Expert Board Co-Chair, on being awarded the prestigious Honorary Member of the Order of the British Empire (MBE) in recognition of her outstanding contributions to neurology and neuromuscular ...Read more ...
- CMT-SORD: Bringing the Science Down to Earth | Shooting Star Ep. 3Shooting Star brings science down to Earth, making complex CMT topics easy to understand. Created and hosted by the Charcot-Marie-Tooth Association (CMTA) youth group, this lively YouTube series blends creativity and enthusiasm with important updates on CMTA programs, research, and ...Read more ...
- Learn How CMTA is Accelerating Research and Empowering PatientsThe Charcot-Marie-Tooth Association (CMTA) is transforming the future of CMT research, CMT treatments, and CMT care by accelerating research and empowering patients. Through CMTA’s Strategy To Accelerate Research (CMTA-STAR), we unite industry leaders, scientists, clinicians, and the CMT community to ...Read more ...
- CMTA Invests $423K to Accelerate CMT Diagnostics and Gene DiscoveryCMTA announced today a $423,000 investment to address diagnostic gaps and drive new CMT gene discoveries. Led by CMTA-STAR Advisory Board Member Stephan Züchner, MD, PhD, at The GENESIS Project Foundation, this investment will expand the GENESIS database and research ...Read more ...
Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
